Technical Analysis for GDR - Genedrive Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Historical GDR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bullish | Bullish Swing Setup | 20.97% | |
| Volume Surge | Other | 20.97% | |
| Wide Range Bar | Range Expansion | 20.97% | |
| Upper Bollinger Band Walk | Strength | 20.97% | |
| Wide Bands | Range Expansion | 20.97% | |
| Upper Bollinger Band Touch | Strength | 20.97% | |
| Volume Surge | Other | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 5x Volume Pace | 30 minutes ago |
| 3x Volume Pace | 30 minutes ago |
| 2x Volume Pace | 30 minutes ago |
| 1.5x Volume Pace | 30 minutes ago |
| 10x Volume Pace | 30 minutes ago |
Get a Trading Assistant
Genedrive Plc Description
Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Gas Biotechnology Clinic Disease Life Sciences Testing Drugs Oncology Skin Health Sciences Laser Skin Care E Testing Omics Clinical Research Drug Development Molecular Pharmacology Medical Genetics Microscopy Profiling Clinical Research Services Genomics Genomics Services Molecular Diagnostics Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|---|
| Aug 16 | A Look At The Fair Value Of genedrive plc (LON:GDR) |
| Indicator | Value |
|---|---|
| 52 Week High | 165.0 |
| 52 Week Low | 15.7501 |
| Average Volume | 2,851,538 |
| 200-Day Moving Average | 56.99 |
| 50-Day Moving Average | 22.43 |
| 20-Day Moving Average | 21.68 |
| 10-Day Moving Average | 24.15 |
| Average True Range | 4.08 |
| ADX | 48.33 |
| +DI | 47.98 |
| -DI | 14.98 |
| Chandelier Exit (Long, 3 ATRs) | 35.77 |
| Chandelier Exit (Short, 3 ATRs) | 27.98 |
| Upper Bollinger Bands | 34.96 |
| Lower Bollinger Band | 8.39 |
| Percent B (%b) | 0.85 |
| BandWidth | 122.57 |
| MACD Line | 2.30 |
| MACD Signal Line | 0.13 |
| MACD Histogram | 2.1752 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 45.25 | ||||
| Resistance 3 (R3) | 46.67 | 43.33 | 42.88 | ||
| Resistance 2 (R2) | 43.33 | 39.70 | 42.63 | 42.08 | |
| Resistance 1 (R1) | 37.17 | 37.46 | 35.50 | 35.75 | 41.29 |
| Pivot Point | 33.83 | 33.83 | 33.00 | 33.13 | 33.83 |
| Support 1 (S1) | 27.67 | 30.20 | 26.00 | 26.25 | 20.71 |
| Support 2 (S2) | 24.33 | 27.96 | 23.63 | 19.92 | |
| Support 3 (S3) | 18.17 | 24.33 | 19.13 | ||
| Support 4 (S4) | 16.75 |
